Tissue Engineered Models of Brain Tumors and Their Applications

101

[65] K. I. Woroniecka, K. E. Rhodin, and P. Chongsathidkiet et al., “T-

cell dysfunction in glioblastoma: applying a new framework,” Clinical

Cancer Research, vol. 24, no. 16, pp. 3792–3802, 2018.

[66] M. Ott, K.-H. Tomaszowski, and A. Marisetty et al., “Profiling of pa-

tients with glioma reveals the dominant immunosuppressive axis is re-

fractory to immune function restoration,” JCI Insight, vol. 5, no. 17,

p. e134386, 2020.

[67] J. F. M. Jacobs, A. J. Idema, and K. F. Bol et al., “Prognostic sig-

nificance and mechanism of Treg infiltration in human brain tumors,”

Journal of Neuroimmunology, vol. 225, no. 1-2, pp. 195–199, 2010.

[68] J. T. Jordan, W. Sun, and S. F. Hussain et al., “Preferential migra-

tion of regulatory T cells mediated by glioma-secreted chemokines can

be blocked with chemotherapy,” Cancer Immunology, Immunotherapy,

vol. 57, pp. 123–131, 2008.

[69] D. A. Wainwright, I. V. Balyasnikova, and A. L. Chang et al., “IDO

expression in brain tumors increases the recruitment of regulatory T

cells and negatively impacts survival,” Clinical Cancer Research, vol. 18,

no. 22, pp. 6110–6121, 2012.

[70] A. Facciabene, X. Peng, and I. S. Hagemann et al., “Tumour hypoxia

promotes tolerance and angiogenesis via CCL28 and Treg cells,” vol. 475,

pp. 226–230, 2011.

[71] M. M. Grabowski, E. W. Sankey, and K. J. Ryan et al., “Immune sup-

pression in gliomas,” Journal of Neuro-oncology, vol. 151, pp. 3–12, 2021.

[72] Y. Yang, C. Li, and T. Liu et al., “Myeloid-derived suppressor cells in

tumors: from mechanisms to antigen specificity and microenvironmental

regulation,” Frontiers in Immunology, vol. 11, 2020.

[73] S. C. Bischoff, “Role of mast cells in allergic and non-allergic immune

responses: comparison of human and murine data,” Nature Reviews Im-

munology, vol. 7, no. 2, pp. 93–104, 2007.

[74] J. Põlajeva, A. M. Sjösten, and N. Lager et al., “Mast cell accumulation

in glioblastoma with a potential role for stem cell factor and chemokine

CXCL12,” PLOS ONE, vol. 6, no. 9, p. e25222, 2011.

[75] A. Roy, A. Coum, and V. D. Marinescu et al., “Glioma-derived plas-

minogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1

positive mast cells,” Oncotarget, vol. 6, no. 27, pp. 23647–23661, 2015.

[76] S. Attarha, A. Roy, and B. Westermark et al., “Mast cells modulate pro-

liferation, migration and stemness of glioma cells through downregula-

tion of GSK3β expression and inhibition of STAT3 activation,” Cellular

Signalling, vol. 37, pp. 81–92, 2017.